Trial Profile
Clinical Phase II Trial of 5-Aminolevulinic Acid Hydrochloride (5-ALA, 5-ALS) for Fluorescence-Guided Resection of Malignant Glioma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Glioma
- Focus Diagnostic use
- 15 Sep 2016 New trial record